nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—type 2 diabetes mellitus	0.389	1	CbGaD
Fosamprenavir—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0638	0.152	CbGbCtD
Fosamprenavir—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0568	0.136	CbGbCtD
Fosamprenavir—CYP3A4—Glipizide—type 2 diabetes mellitus	0.052	0.124	CbGbCtD
Fosamprenavir—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0454	0.109	CbGbCtD
Fosamprenavir—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0411	0.0982	CbGbCtD
Fosamprenavir—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0311	0.0744	CbGbCtD
Fosamprenavir—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0298	0.0713	CbGbCtD
Fosamprenavir—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0298	0.0713	CbGbCtD
Fosamprenavir—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0282	0.0675	CbGbCtD
Fosamprenavir—CYP3A4—Glyburide—type 2 diabetes mellitus	0.021	0.0503	CbGbCtD
Fosamprenavir—CYP3A4—Losartan—type 2 diabetes mellitus	0.0192	0.046	CbGbCtD
Fosamprenavir—Darunavir—CYP3A4—type 2 diabetes mellitus	0.00194	0.707	CrCbGaD
Fosamprenavir—Amprenavir—CYP3A4—type 2 diabetes mellitus	0.000806	0.293	CrCbGaD
Fosamprenavir—Flatulence—Valsartan—type 2 diabetes mellitus	0.000269	0.00142	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000268	0.00141	CcSEcCtD
Fosamprenavir—Rash—Repaglinide—type 2 diabetes mellitus	0.000268	0.00141	CcSEcCtD
Fosamprenavir—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000268	0.00141	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000267	0.00141	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000267	0.00141	CcSEcCtD
Fosamprenavir—Flatulence—Orlistat—type 2 diabetes mellitus	0.000266	0.0014	CcSEcCtD
Fosamprenavir—Headache—Repaglinide—type 2 diabetes mellitus	0.000266	0.0014	CcSEcCtD
Fosamprenavir—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000265	0.0014	CcSEcCtD
Fosamprenavir—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000265	0.0014	CcSEcCtD
Fosamprenavir—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000265	0.0014	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000265	0.0014	CcSEcCtD
Fosamprenavir—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000265	0.00139	CcSEcCtD
Fosamprenavir—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000259	0.00137	CcSEcCtD
Fosamprenavir—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000259	0.00137	CcSEcCtD
Fosamprenavir—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000258	0.00136	CcSEcCtD
Fosamprenavir—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000258	0.00136	CcSEcCtD
Fosamprenavir—Anorexia—Glyburide—type 2 diabetes mellitus	0.000258	0.00136	CcSEcCtD
Fosamprenavir—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000257	0.00136	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000255	0.00135	CcSEcCtD
Fosamprenavir—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000255	0.00134	CcSEcCtD
Fosamprenavir—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000254	0.00134	CcSEcCtD
Fosamprenavir—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000253	0.00134	CcSEcCtD
Fosamprenavir—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000253	0.00133	CcSEcCtD
Fosamprenavir—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000253	0.00133	CcSEcCtD
Fosamprenavir—Nausea—Repaglinide—type 2 diabetes mellitus	0.000252	0.00133	CcSEcCtD
Fosamprenavir—Asthenia—Glipizide—type 2 diabetes mellitus	0.000252	0.00133	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000252	0.00133	CcSEcCtD
Fosamprenavir—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000251	0.00133	CcSEcCtD
Fosamprenavir—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.00025	0.00132	CcSEcCtD
Fosamprenavir—Angioedema—Valsartan—type 2 diabetes mellitus	0.00025	0.00132	CcSEcCtD
Fosamprenavir—Malnutrition—Metformin—type 2 diabetes mellitus	0.000249	0.00131	CcSEcCtD
Fosamprenavir—Pruritus—Glipizide—type 2 diabetes mellitus	0.000249	0.00131	CcSEcCtD
Fosamprenavir—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000248	0.00131	CcSEcCtD
Fosamprenavir—Angioedema—Orlistat—type 2 diabetes mellitus	0.000247	0.0013	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000246	0.0013	CcSEcCtD
Fosamprenavir—Flatulence—Metformin—type 2 diabetes mellitus	0.000245	0.00129	CcSEcCtD
Fosamprenavir—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000244	0.00129	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000242	0.00128	CcSEcCtD
Fosamprenavir—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000242	0.00127	CcSEcCtD
Fosamprenavir—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000242	0.00127	CcSEcCtD
Fosamprenavir—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000241	0.00127	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.00024	0.00127	CcSEcCtD
Fosamprenavir—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00024	0.00127	CcSEcCtD
Fosamprenavir—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.00024	0.00127	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000239	0.00126	CcSEcCtD
Fosamprenavir—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000238	0.00126	CcSEcCtD
Fosamprenavir—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000238	0.00126	CcSEcCtD
Fosamprenavir—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000238	0.00125	CcSEcCtD
Fosamprenavir—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000236	0.00124	CcSEcCtD
Fosamprenavir—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000235	0.00124	CcSEcCtD
Fosamprenavir—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000235	0.00124	CcSEcCtD
Fosamprenavir—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000235	0.00124	CcSEcCtD
Fosamprenavir—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000235	0.00124	CcSEcCtD
Fosamprenavir—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000234	0.00123	CcSEcCtD
Fosamprenavir—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000234	0.00123	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000233	0.00123	CcSEcCtD
Fosamprenavir—Myalgia—Valsartan—type 2 diabetes mellitus	0.000233	0.00123	CcSEcCtD
Fosamprenavir—Dizziness—Glipizide—type 2 diabetes mellitus	0.000232	0.00123	CcSEcCtD
Fosamprenavir—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000232	0.00122	CcSEcCtD
Fosamprenavir—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000231	0.00122	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000231	0.00122	CcSEcCtD
Fosamprenavir—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00023	0.00121	CcSEcCtD
Fosamprenavir—Myalgia—Orlistat—type 2 diabetes mellitus	0.00023	0.00121	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000228	0.0012	CcSEcCtD
Fosamprenavir—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000224	0.00118	CcSEcCtD
Fosamprenavir—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000224	0.00118	CcSEcCtD
Fosamprenavir—Vomiting—Glipizide—type 2 diabetes mellitus	0.000223	0.00118	CcSEcCtD
Fosamprenavir—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000223	0.00117	CcSEcCtD
Fosamprenavir—Rash—Glipizide—type 2 diabetes mellitus	0.000222	0.00117	CcSEcCtD
Fosamprenavir—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000221	0.00117	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000221	0.00117	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000221	0.00117	CcSEcCtD
Fosamprenavir—Headache—Glipizide—type 2 diabetes mellitus	0.00022	0.00116	CcSEcCtD
Fosamprenavir—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000219	0.00115	CcSEcCtD
Fosamprenavir—Flatulence—Losartan—type 2 diabetes mellitus	0.000218	0.00115	CcSEcCtD
Fosamprenavir—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000217	0.00114	CcSEcCtD
Fosamprenavir—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000217	0.00114	CcSEcCtD
Fosamprenavir—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000216	0.00114	CcSEcCtD
Fosamprenavir—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00114	CcSEcCtD
Fosamprenavir—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000215	0.00113	CcSEcCtD
Fosamprenavir—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000214	0.00113	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000214	0.00113	CcSEcCtD
Fosamprenavir—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000214	0.00113	CcSEcCtD
Fosamprenavir—Anorexia—Valsartan—type 2 diabetes mellitus	0.000213	0.00112	CcSEcCtD
Fosamprenavir—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000212	0.00112	CcSEcCtD
Fosamprenavir—Myalgia—Metformin—type 2 diabetes mellitus	0.000212	0.00112	CcSEcCtD
Fosamprenavir—Headache—Pioglitazone—type 2 diabetes mellitus	0.000211	0.00111	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00021	0.00111	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00021	0.00111	CcSEcCtD
Fosamprenavir—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000209	0.0011	CcSEcCtD
Fosamprenavir—Nausea—Glipizide—type 2 diabetes mellitus	0.000209	0.0011	CcSEcCtD
Fosamprenavir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000208	0.0011	CcSEcCtD
Fosamprenavir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000208	0.0011	CcSEcCtD
Fosamprenavir—Rash—Glimepiride—type 2 diabetes mellitus	0.000207	0.00109	CcSEcCtD
Fosamprenavir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000207	0.00109	CcSEcCtD
Fosamprenavir—Rash—Sitagliptin—type 2 diabetes mellitus	0.000206	0.00109	CcSEcCtD
Fosamprenavir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000206	0.00109	CcSEcCtD
Fosamprenavir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000206	0.00109	CcSEcCtD
Fosamprenavir—Headache—Glimepiride—type 2 diabetes mellitus	0.000205	0.00108	CcSEcCtD
Fosamprenavir—Headache—Sitagliptin—type 2 diabetes mellitus	0.000205	0.00108	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000203	0.00107	CcSEcCtD
Fosamprenavir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000202	0.00107	CcSEcCtD
Fosamprenavir—Angioedema—Losartan—type 2 diabetes mellitus	0.000202	0.00107	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000201	0.00106	CcSEcCtD
Fosamprenavir—Myalgia—Irbesartan—type 2 diabetes mellitus	0.0002	0.00105	CcSEcCtD
Fosamprenavir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000199	0.00105	CcSEcCtD
Fosamprenavir—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000199	0.00105	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000199	0.00105	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000199	0.00105	CcSEcCtD
Fosamprenavir—Skin disorder—Metformin—type 2 diabetes mellitus	0.000197	0.00104	CcSEcCtD
Fosamprenavir—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000197	0.00104	CcSEcCtD
Fosamprenavir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00103	CcSEcCtD
Fosamprenavir—Nausea—Glimepiride—type 2 diabetes mellitus	0.000195	0.00103	CcSEcCtD
Fosamprenavir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000194	0.00102	CcSEcCtD
Fosamprenavir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000194	0.00102	CcSEcCtD
Fosamprenavir—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000194	0.00102	CcSEcCtD
Fosamprenavir—Anorexia—Metformin—type 2 diabetes mellitus	0.000194	0.00102	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000193	0.00102	CcSEcCtD
Fosamprenavir—Fatigue—Valsartan—type 2 diabetes mellitus	0.000192	0.00101	CcSEcCtD
Fosamprenavir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000192	0.00101	CcSEcCtD
Fosamprenavir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000192	0.00101	CcSEcCtD
Fosamprenavir—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000192	0.00101	CcSEcCtD
Fosamprenavir—Pruritus—Glyburide—type 2 diabetes mellitus	0.000191	0.00101	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00019	0.001	CcSEcCtD
Fosamprenavir—Fatigue—Orlistat—type 2 diabetes mellitus	0.00019	0.001	CcSEcCtD
Fosamprenavir—Malnutrition—Ramipril—type 2 diabetes mellitus	0.00019	0.001	CcSEcCtD
Fosamprenavir—Myalgia—Losartan—type 2 diabetes mellitus	0.000188	0.000992	CcSEcCtD
Fosamprenavir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000188	0.000992	CcSEcCtD
Fosamprenavir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000188	0.000991	CcSEcCtD
Fosamprenavir—Rash—Bromocriptine—type 2 diabetes mellitus	0.000187	0.000983	CcSEcCtD
Fosamprenavir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000186	0.000983	CcSEcCtD
Fosamprenavir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000186	0.000982	CcSEcCtD
Fosamprenavir—Headache—Bromocriptine—type 2 diabetes mellitus	0.000185	0.000977	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000185	0.000976	CcSEcCtD
Fosamprenavir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000185	0.000976	CcSEcCtD
Fosamprenavir—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000183	0.000964	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000182	0.000962	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00018	0.000951	CcSEcCtD
Fosamprenavir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000179	0.000943	CcSEcCtD
Fosamprenavir—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000177	0.000933	CcSEcCtD
Fosamprenavir—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000177	0.000931	CcSEcCtD
Fosamprenavir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000176	0.00093	CcSEcCtD
Fosamprenavir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000176	0.000927	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000175	0.000925	CcSEcCtD
Fosamprenavir—Fatigue—Metformin—type 2 diabetes mellitus	0.000175	0.000924	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000175	0.000921	CcSEcCtD
Fosamprenavir—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000174	0.000919	CcSEcCtD
Fosamprenavir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000174	0.000919	CcSEcCtD
Fosamprenavir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000174	0.000919	CcSEcCtD
Fosamprenavir—Angioedema—Ramipril—type 2 diabetes mellitus	0.000173	0.000913	CcSEcCtD
Fosamprenavir—Anorexia—Losartan—type 2 diabetes mellitus	0.000172	0.000907	CcSEcCtD
Fosamprenavir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000172	0.000907	CcSEcCtD
Fosamprenavir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000172	0.000906	CcSEcCtD
Fosamprenavir—Rash—Glyburide—type 2 diabetes mellitus	0.000171	0.000899	CcSEcCtD
Fosamprenavir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00017	0.000898	CcSEcCtD
Fosamprenavir—Headache—Glyburide—type 2 diabetes mellitus	0.000169	0.000893	CcSEcCtD
Fosamprenavir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000167	0.000879	CcSEcCtD
Fosamprenavir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000166	0.000876	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000166	0.000876	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000166	0.000873	CcSEcCtD
Fosamprenavir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000165	0.000872	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000164	0.000867	CcSEcCtD
Fosamprenavir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000164	0.000867	CcSEcCtD
Fosamprenavir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000162	0.000856	CcSEcCtD
Fosamprenavir—Myalgia—Ramipril—type 2 diabetes mellitus	0.000161	0.000851	CcSEcCtD
Fosamprenavir—Nausea—Glyburide—type 2 diabetes mellitus	0.000161	0.000847	CcSEcCtD
Fosamprenavir—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000161	0.000847	CcSEcCtD
Fosamprenavir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000161	0.000847	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00016	0.000845	CcSEcCtD
Fosamprenavir—Asthenia—Valsartan—type 2 diabetes mellitus	0.00016	0.000844	CcSEcCtD
Fosamprenavir—Asthenia—Orlistat—type 2 diabetes mellitus	0.000158	0.000834	CcSEcCtD
Fosamprenavir—Pruritus—Valsartan—type 2 diabetes mellitus	0.000158	0.000832	CcSEcCtD
Fosamprenavir—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000157	0.000827	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000157	0.000827	CcSEcCtD
Fosamprenavir—Pruritus—Orlistat—type 2 diabetes mellitus	0.000156	0.000822	CcSEcCtD
Fosamprenavir—Fatigue—Losartan—type 2 diabetes mellitus	0.000156	0.00082	CcSEcCtD
Fosamprenavir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000154	0.000814	CcSEcCtD
Fosamprenavir—Rash—Gliclazide—type 2 diabetes mellitus	0.000153	0.000807	CcSEcCtD
Fosamprenavir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000153	0.000807	CcSEcCtD
Fosamprenavir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000153	0.000805	CcSEcCtD
Fosamprenavir—Headache—Gliclazide—type 2 diabetes mellitus	0.000152	0.000802	CcSEcCtD
Fosamprenavir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000152	0.0008	CcSEcCtD
Fosamprenavir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000152	0.000799	CcSEcCtD
Fosamprenavir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000152	0.000799	CcSEcCtD
Fosamprenavir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000151	0.000795	CcSEcCtD
Fosamprenavir—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00015	0.000792	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000148	0.000778	CcSEcCtD
Fosamprenavir—Dizziness—Valsartan—type 2 diabetes mellitus	0.000148	0.000778	CcSEcCtD
Fosamprenavir—Anorexia—Ramipril—type 2 diabetes mellitus	0.000147	0.000778	CcSEcCtD
Fosamprenavir—Dizziness—Orlistat—type 2 diabetes mellitus	0.000146	0.000769	CcSEcCtD
Fosamprenavir—Asthenia—Metformin—type 2 diabetes mellitus	0.000146	0.000769	CcSEcCtD
Fosamprenavir—Nausea—Gliclazide—type 2 diabetes mellitus	0.000144	0.000761	CcSEcCtD
Fosamprenavir—Pruritus—Metformin—type 2 diabetes mellitus	0.000144	0.000758	CcSEcCtD
Fosamprenavir—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000143	0.000752	CcSEcCtD
Fosamprenavir—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000143	0.000752	CcSEcCtD
Fosamprenavir—Vomiting—Valsartan—type 2 diabetes mellitus	0.000142	0.000748	CcSEcCtD
Fosamprenavir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000141	0.000745	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000141	0.000743	CcSEcCtD
Fosamprenavir—Rash—Valsartan—type 2 diabetes mellitus	0.000141	0.000742	CcSEcCtD
Fosamprenavir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000141	0.000741	CcSEcCtD
Fosamprenavir—Vomiting—Orlistat—type 2 diabetes mellitus	0.00014	0.000739	CcSEcCtD
Fosamprenavir—Headache—Valsartan—type 2 diabetes mellitus	0.00014	0.000737	CcSEcCtD
Fosamprenavir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000139	0.000733	CcSEcCtD
Fosamprenavir—Rash—Orlistat—type 2 diabetes mellitus	0.000139	0.000733	CcSEcCtD
Fosamprenavir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000139	0.000732	CcSEcCtD
Fosamprenavir—Headache—Orlistat—type 2 diabetes mellitus	0.000138	0.000728	CcSEcCtD
Fosamprenavir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000138	0.000725	CcSEcCtD
Fosamprenavir—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000136	0.000715	CcSEcCtD
Fosamprenavir—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000134	0.000709	CcSEcCtD
Fosamprenavir—Dizziness—Metformin—type 2 diabetes mellitus	0.000134	0.000708	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000134	0.000704	CcSEcCtD
Fosamprenavir—Fatigue—Ramipril—type 2 diabetes mellitus	0.000133	0.000703	CcSEcCtD
Fosamprenavir—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000133	0.000701	CcSEcCtD
Fosamprenavir—Nausea—Valsartan—type 2 diabetes mellitus	0.000133	0.000699	CcSEcCtD
Fosamprenavir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000131	0.000692	CcSEcCtD
Fosamprenavir—Nausea—Orlistat—type 2 diabetes mellitus	0.000131	0.00069	CcSEcCtD
Fosamprenavir—Asthenia—Losartan—type 2 diabetes mellitus	0.000129	0.000683	CcSEcCtD
Fosamprenavir—Vomiting—Metformin—type 2 diabetes mellitus	0.000129	0.000681	CcSEcCtD
Fosamprenavir—Rash—Metformin—type 2 diabetes mellitus	0.000128	0.000675	CcSEcCtD
Fosamprenavir—Dermatitis—Metformin—type 2 diabetes mellitus	0.000128	0.000675	CcSEcCtD
Fosamprenavir—Pruritus—Losartan—type 2 diabetes mellitus	0.000128	0.000673	CcSEcCtD
Fosamprenavir—Headache—Metformin—type 2 diabetes mellitus	0.000127	0.000671	CcSEcCtD
Fosamprenavir—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000127	0.000669	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000127	0.000667	CcSEcCtD
Fosamprenavir—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000123	0.000651	CcSEcCtD
Fosamprenavir—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000122	0.000645	CcSEcCtD
Fosamprenavir—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000122	0.000645	CcSEcCtD
Fosamprenavir—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000122	0.000643	CcSEcCtD
Fosamprenavir—Rash—Irbesartan—type 2 diabetes mellitus	0.000121	0.000637	CcSEcCtD
Fosamprenavir—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000121	0.000637	CcSEcCtD
Fosamprenavir—Nausea—Metformin—type 2 diabetes mellitus	0.000121	0.000636	CcSEcCtD
Fosamprenavir—Headache—Irbesartan—type 2 diabetes mellitus	0.00012	0.000633	CcSEcCtD
Fosamprenavir—Dizziness—Losartan—type 2 diabetes mellitus	0.000119	0.000629	CcSEcCtD
Fosamprenavir—Vomiting—Losartan—type 2 diabetes mellitus	0.000115	0.000605	CcSEcCtD
Fosamprenavir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000114	0.000601	CcSEcCtD
Fosamprenavir—Nausea—Irbesartan—type 2 diabetes mellitus	0.000114	0.0006	CcSEcCtD
Fosamprenavir—Rash—Losartan—type 2 diabetes mellitus	0.000114	0.0006	CcSEcCtD
Fosamprenavir—Dermatitis—Losartan—type 2 diabetes mellitus	0.000114	0.000599	CcSEcCtD
Fosamprenavir—Headache—Losartan—type 2 diabetes mellitus	0.000113	0.000596	CcSEcCtD
Fosamprenavir—Asthenia—Ramipril—type 2 diabetes mellitus	0.000111	0.000585	CcSEcCtD
Fosamprenavir—Pruritus—Ramipril—type 2 diabetes mellitus	0.000109	0.000577	CcSEcCtD
Fosamprenavir—Nausea—Losartan—type 2 diabetes mellitus	0.000107	0.000565	CcSEcCtD
Fosamprenavir—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000106	0.000558	CcSEcCtD
Fosamprenavir—Dizziness—Ramipril—type 2 diabetes mellitus	0.000102	0.000539	CcSEcCtD
Fosamprenavir—Vomiting—Ramipril—type 2 diabetes mellitus	9.84e-05	0.000519	CcSEcCtD
Fosamprenavir—Rash—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000514	CcSEcCtD
Fosamprenavir—Dermatitis—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000514	CcSEcCtD
Fosamprenavir—Headache—Ramipril—type 2 diabetes mellitus	9.69e-05	0.000511	CcSEcCtD
Fosamprenavir—Nausea—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000485	CcSEcCtD
